Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL  and COIN-B trials in the ARCAD database

Patients with left-sided colon tumours have better survival and respond differently to biologics compared with patients with right-sided tumours. Left-sided colon tumours and rectal cancers are often grouped together. Herein, we examined the clinicopathological differences and outcomes between left-sided colon and rectal cancers.

Source: European Journal of Cancer - September 27, 2018 Category: Cancer & Oncology Authors: Mohamed E. Salem, Jun Yin, Benjamin A. Weinberg, Lindsay A. Renfro, Levi D. Pederson, Timothy S. Maughan, Richard A. Adams, Eric Van Cutsem, Alfredo Falcone, Niall C. Tebbutt, Matthew T. Seymour, Eduardo D íaz-Rubio, Enrique Aranda, Carsten Bokemeyer, Vo Tags: Original Research Source Type: research